Companies that lack a pricing culture succumb to cost-based as well as reactive pricing methods in lieu of using more proactive and strategic approaches.
Peter L. Louie, MBA, PhD
Peter L. Louie, MBA, PhD, is a consultant for the life science/biotech industry. His education background includes a Ph.D. in biochemistry from UC Riverside and an MBA from Pepperdine University. He has served in various capacities in the life science/biotech industry, from R&D to Services and Marketing in leading life science companies, including Syntex Pharmaceuticals, QIAGEN, and Beckman Coulter. His expertise includes product development, strategic planning, global market management, and new business development for life science companies.